Earnings Releases·Nov 2, 2026, 4:05 PM ET

Sabra Health Care REIT, Inc. — Third Quarter 2026 Earnings Summary

Q3 2026 net income per diluted share rose to $0.11 from $0.09 in Q3 2025, while FFO, Normalized FFO, and AFFO per share increased to $0.40, $0.39, and $0.45 respectively, compared to $0.33, $0.36, and $0.37 in the prior year period; total revenues reached $249.6 million versus $190.0 million in Q3 2025.
Management raised full-year 2026 guidance for Net Income ($0.265–$0.275), FFO ($1.145–$1.155), Normalized FFO ($1.540–$1.550), AFFO ($1.625–$1.635), and Normalized AFFO ($1.600–$1.610), assuming mid-teens Cash NOI growth for same-store SHOP and low-single-digit growth for the triple-net portfolio.
Strategic portfolio shifts accelerated with the acquisition of seven SHOP communities for $222.8 million in Q3 and $747.2 million in year-to-date investments, alongside the transition of 26 properties to new tenants that increased annualized cash rent to $53 million, with SHOP concentration expected to reach 40% by year-end 2026.
The Board declared a $0.30 quarterly dividend payable November 30, 2026, while liquidity stood at approximately $1.2 billion, supported by $873.5 million in available revolver borrowings and $332.7 million remaining under the ATM program.